# Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

> **NCT05211011** · PHASE4 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 226 (actual)

## Conditions studied

- Prosthetic Joint Infection

## Interventions

- **DRUG:** Fosfomycin

## Key facts

- **NCT ID:** NCT05211011
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-23
- **Primary completion:** 2022-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2022-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05211011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05211011, "Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05211011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*